Dr. David Mason, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,740 | 6 | 51.1% |
| Honoraria | $4,500 | 1 | 21.4% |
| Food and Beverage | $3,836 | 159 | 18.2% |
| Travel and Lodging | $1,019 | 10 | 4.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $930.00 | 1 | 4.4% |
| Entertainment | $11.51 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $10,854 | 11 | $0 (2024) |
| Novocure Inc. | $4,864 | 8 | $0 (2021) |
| Olympus Corporation of the Americas | $1,105 | 11 | $0 (2022) |
| Medtronic, Inc. | $948.76 | 2 | $0 (2023) |
| Ethicon US, LLC | $240.18 | 11 | $0 (2023) |
| TELA Bio, Inc. | $220.45 | 12 | $0 (2024) |
| ATRICURE, INC. | $191.71 | 9 | $0 (2024) |
| Olympus America Inc. | $190.18 | 9 | $0 (2022) |
| Ambu Inc. | $182.32 | 3 | $0 (2024) |
| Intuitive Surgical, Inc. | $162.27 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,964 | 10 | AstraZeneca Pharmaceuticals LP ($1,611) |
| 2023 | $4,958 | 17 | AstraZeneca Pharmaceuticals LP ($3,759) |
| 2022 | $1,428 | 25 | Olympus Corporation of the Americas ($1,105) |
| 2021 | $3,400 | 30 | AstraZeneca Pharmaceuticals LP ($2,733) |
| 2020 | $3,015 | 15 | AstraZeneca Pharmaceuticals LP ($2,712) |
| 2019 | $5,176 | 23 | Novocure Inc. ($4,744) |
| 2018 | $458.32 | 24 | Becton, Dickinson and Company ($86.35) |
| 2017 | $637.62 | 34 | Mallinckrodt LLC ($95.86) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | ATRICURE, INC. | ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/31/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Surgical Mesh | ||||||
| 06/20/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $99.25 | General |
| 06/20/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| 05/20/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $64.08 | General |
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
| 04/09/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $53.04 | General |
| Category: Surgical Care | ||||||
| 02/28/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: Surgical Mesh | ||||||
| 02/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: ONCOLOGY | ||||||
| 12/28/2023 | Integra LifeSciences Corporation | BIOFIX (Device), BIODRESTORE, BIODFACTOR | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Othobio | ||||||
| 12/20/2023 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Surgical Mesh | ||||||
| 11/21/2023 | Ethicon US, LLC | Echelon Flex (Device) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Endo-Mechanical | ||||||
| 11/03/2023 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Surgical Mesh | ||||||
| 10/27/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
| Category: Oncology | ||||||
| 10/03/2023 | KARL STORZ Endoscopy-America | — | Food and Beverage | In-kind items and services | $41.01 | General |
| 09/20/2023 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Surgical Mesh | ||||||
| 09/06/2023 | Davol Inc. | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Surgery | ||||||
| 08/31/2023 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| 07/27/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Neuroscience | ||||||
| 05/10/2023 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Surgical Stapling | ||||||
| 04/27/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Vaccines | ||||||
| 04/19/2023 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Surgical Mesh | ||||||
| 03/12/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Oncology | ||||||
| 03/01/2023 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Surgical Mesh | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 166 | 230 | $69,229 | $18,775 |
| 2022 | 4 | 99 | 108 | $35,597 | $10,496 |
| 2021 | 3 | 157 | 182 | $29,925 | $15,135 |
| 2020 | 7 | 258 | 296 | $124,135 | $46,694 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 121 | $28,193 | $7,818 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $25,560 | $7,225 | 28.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,760 | $1,431 | 30.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 19 | $3,420 | $1,183 | 34.6% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 11 | 16 | $7,296 | $1,118 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $20,022 | $5,797 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 38 | $8,854 | $2,666 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 12 | $3,960 | $1,170 | 29.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,761 | $863.97 | 31.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 65 | 65 | $18,200 | $8,100 | 44.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 89 | $9,345 | $6,128 | 65.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 28 | $2,380 | $907.70 | 38.1% |
| 32663 | Examination of lung with removal of lung lobe using an endoscope | Facility | 2020 | 17 | 17 | $50,150 | $19,339 | 38.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 100 | 100 | $28,000 | $12,904 | 46.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 75 | 108 | $11,340 | $6,312 | 55.7% |
| 39402 | Examination of chest using an endoscope with lymph node biopsy | Facility | 2020 | 14 | 14 | $14,518 | $3,239 | 22.3% |
| 32674 | Removal of lymph nodes of mid-chest cavity using an endoscope | Facility | 2020 | 18 | 18 | $9,756 | $3,143 | 32.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 23 | 27 | $2,295 | $878.47 | 38.3% |
| 31622 | Diagnostic examination of lung airways using an endoscope | Facility | 2020 | 11 | 12 | $8,076 | $878.22 | 10.9% |
About Dr. David Mason, M.D
Dr. David Mason, M.D is a Thoracic Surgery (Cardiothoracic Vascular Surgery) healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083678155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Mason, M.D has received a total of $21,036 in payments from pharmaceutical and medical device companies, with $1,964 received in 2024. These payments were reported across 178 transactions from 52 companies. The most common payment nature is "Consulting Fee" ($10,740).
As a Medicare-enrolled provider, Mason has provided services to 680 Medicare beneficiaries, totaling 816 services with total Medicare billing of $91,100. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Thoracic Surgery (Cardiothoracic Vascular Surgery)
- Location Dallas, TX
- Active Since 04/14/2006
- Last Updated 11/16/2021
- Taxonomy Code 208G00000X
- Entity Type Individual
- NPI Number 1083678155
Products in Payments
- TAGRISSO (Drug) $9,204
- Oncology (Device) $4,744
- Single Use Guide Sheath Kit (Device) $1,050
- Da Vinci Surgical System (Device) $162.27
- OFIRMEV (Drug) $139.29
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) $130.21
- PICO (Device) $120.99
- NovoTTF-100L (Device) $120.25
- Spin (Device) $117.55
- Echelon Flex (Device) $87.09
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM (Device) $71.84
- XARELTO (Drug) $67.56
- GIAPREZA (Drug) $66.25
- Spiration Valve System (Device) $65.39
- ON-Q* PUMP AND ACCESSORIES (Device) $60.13
- HANAROSTENT LowAxTM Colon/Rectum(NNN) (Device) $59.89
- Surgicel Powder (Device) $58.34
- ON-Q PUMP AND ACCESSORIES (Device) $57.71
- OviTex 2S (Device) $55.16
- SINGLE USE SUCTION VALVE (Sterile) (Device) $55.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Dallas
Robert Hebeler, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $2.9M
Juan Machannaford, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $162,025
Dr. Todd Dewey, M.d, M.D
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $135,397
Dan Meyer, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $36,069
Albert Henry, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $35,576
Dr. Mini Sivadasan, M.d, M.D
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $20,373